When.com Web Search

  1. Ads

    related to: treatment for mild intermittent asthma

Search results

  1. Results From The WOW.Com Content Network
  2. Reactive airway disease - Wikipedia

    en.wikipedia.org/wiki/Reactive_airway_disease

    Reactive airways dysfunction syndrome was first identified by Stuart M. Brooks and colleagues in 1985 as an asthma-like syndrome developing after a single exposure to high levels of an irritating vapor, fume, or smoke. [1][5] It can manifest in adults with exposure to high levels of chlorine, ammonia, acetic acid, or sulphur dioxide, creating ...

  3. If You're Living With Asthma, Here's Every Single Treatment ...

    www.aol.com/lifestyle/youre-living-asthma-heres...

    Treat an asthma attack by visiting the hospital. Every year, more than 1.6 million Americans wind up in the emergency room because of an asthma attack, according to the CDC.If your attack is so ...

  4. Asthma - Wikipedia

    en.wikipedia.org/wiki/Asthma

    Asthma is a long-term inflammatory disease of the airways of the lungs. [4] It is characterized by variable and recurring symptoms, reversible airflow obstruction, and easily triggered bronchospasms. [9][10] Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath. [3]

  5. Everything You Need to Know About Asthma, from Symptoms to ...

    www.aol.com/everything-know-asthma-symptoms...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Anti-asthmatic agents - Wikipedia

    en.wikipedia.org/wiki/Anti-asthmatic_agents

    Anti-asthmatic agents. Anti-asthmatic agents refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies and related ...

  7. First Advanced Oral Treatment For Asthma - Sanofi's ... - AOL

    www.aol.com/first-advanced-oral-treatment-asthma...

    Wednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in adult patients with uncontrolled moderate-to-severe asthma. Two doses of rilzabrutinib, 800 mg ...

  1. Ad

    related to: treatment for mild intermittent asthma